Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
Epigenetic alterations, as a cancer hallmark, are associated with cancer initiation, progression and aggressiveness. Considering, however, that these alterations are reversible, drugs that target epigenetic machinery may have an inhibitory effect upon cancer treatment. The traditional drug discovery...
Main Authors: | Filipa Moreira-Silva, Vânia Camilo, Vítor Gaspar, João F. Mano, Rui Henrique, Carmen Jerónimo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/5/410 |
Similar Items
-
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
by: Hisham F. Bahmad, et al.
Published: (2022-02-01) -
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
by: Michel Montalvo-Casimiro, et al.
Published: (2020-11-01) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021-10-01) -
Repurposing of Drug Candidates for Treatment of Skin Cancer
by: Hernán Cortés, et al.
Published: (2021-01-01) -
Mutuality of epigenetic and nanoparticles: two sides of a coin
by: Maryam sanei, et al.
Published: (2024-01-01)